Fig. 1From: Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience a Actuarial 5-year overall survival (“all causes,” includes three deaths from other causes in patients without evidence of active disease) curve for all 69 stage IB-2 cervical cancer patients as determined by Kaplan–Meier analysis. b Actuarial 5-year survival curve for 58 stage IB-2 cervical cancer patients (with negative nodes at surgery) as determined by Kaplan–Meier analysisBack to article page